ESZ Notification and Conservation Intent

In a significant step for wetland protection in northern India, the Parvati–Arga Bird Sanctuary in Uttar Pradesh has been notified as an Eco-Sensitive Zone (ESZ). The decision was announced by the Union Ministry of Environment, Forest and Climate Change, with Minister of State Kirti Vardhan Singh emphasising the need to safeguard fragile ecosystems while enabling sustainable development. The ESZ designation introduces regulatory oversight on activities surrounding the sanctuary, reducing ecological stress from unplanned construction, pollution, and land-use change.

Historic Feat in Antarctica

India’s adventure sports landscape witnessed a landmark moment as 18-year-old Kaamya Karthikeyan successfully skied to the South Pole, becoming the youngest Indian and the second-youngest woman globally to achieve the feat. She reached the pole on December 27, 2025, after traversing nearly 115 kilometres across Antarctica under some of the harshest conditions on Earth.

Young Climber Shines on National Stage

India’s sport climbing ecosystem received a major boost as 14-year-old Amieyra Khoslla won the gold medal in the Youth Girls (Under-17) category at the 29th National Sport Climbing Championship 2025. The championship was held in Bengaluru from December 26 to 29, bringing together the country’s best young climbers across age groups and disciplines.

Goa Expands Administrative Map

Goa is set to witness a significant administrative reorganisation with the creation of its third district, Kushavati. The announcement was made by Chief Minister Pramod Sawant, marking the first addition to Goa’s district structure since its formation as a state. At present, Goa has only North Goa and South Goa districts.

The new district derives its name from the ancient Kushavati river, reflecting the state’s emphasis on linking administrative reforms with historical and cultural identity.

Rethinking Cancer Drug Resistance

Cancer treatment often faces a critical setback when tumours stop responding to medicines that initially work well. In advanced and metastatic cancers, tumour cells frequently acquire new genetic mutations that allow them to bypass targeted drugs. This acquired resistance remains one of the biggest barriers to durable cancer control, even with cutting-edge therapies.